Research results (total or preliminary) related to treatments of patients with neurodegenerative diseases; behavioral, eating, and mood disorders; autoimmune diseases and/or orphan diseases, as well as the treatment of patients with symptoms such as chronic pain, loss of appetite, among others, that link endocannabinoids, cannabis and/or cannabinoids.